| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |